Seshasayee Paper & Boards Ltd (SESHAPAPER): Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 9:43 am

Competitors of Seshasayee Paper & Boards Ltd (SESHAPAPER)

All Competitor Stocks of Seshasayee Paper & Boards Ltd (SESHAPAPER)

Quarterly Result

Last Updated: August 1, 2025, 12:10 pm

Below is a detailed analysis of the quarterly data for Seshasayee Paper & Boards Ltd (SESHAPAPER) based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 385.00 Cr.. The value appears to be declining and may need further review. It has decreased from 502.00 Cr. (Mar 2025) to 385.00 Cr., marking a decrease of 117.00 Cr..
• For Expenses, as of Jun 2025, the value is 365.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 477.00 Cr. (Mar 2025) to 365.00 Cr., marking a decrease of 112.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 5.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00%.
• For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 6.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 8.00% (Mar 2025) to 28.00%, marking an increase of 20.00%.
• For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 12.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.45. The value appears to be declining and may need further review. It has decreased from 4.29 (Mar 2025) to 2.45, marking a decrease of 1.84.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:29 am

Growth

Last Updated: September 5, 2025, 1:26 pm

Balance Sheet

Last Updated: November 9, 2025, 2:54 pm

Below is a detailed analysis of the balance sheet data for Seshasayee Paper & Boards Ltd (SESHAPAPER) based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
• For Reserves, as of Sep 2025, the value is 2,004.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,976.00 Cr. (Mar 2025) to 2,004.00 Cr., marking an increase of 28.00 Cr..
• For Borrowings, as of Sep 2025, the value is 77.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 82.00 Cr. (Mar 2025) to 77.00 Cr., marking a decrease of 5.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 394.00 Cr.. The value appears to be improving (decreasing). It has decreased from 452.00 Cr. (Mar 2025) to 394.00 Cr., marking a decrease of 58.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,487.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,522.00 Cr. (Mar 2025) to 2,487.00 Cr., marking a decrease of 35.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 773.00 Cr.. The value appears strong and on an upward trend. It has increased from 769.00 Cr. (Mar 2025) to 773.00 Cr., marking an increase of 4.00 Cr..
• For CWIP, as of Sep 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2025) to 73.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Sep 2025, the value is 313.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2025) to 313.00 Cr., marking an increase of 35.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,328.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,404.00 Cr. (Mar 2025) to 1,328.00 Cr., marking a decrease of 76.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,487.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,522.00 Cr. (Mar 2025) to 2,487.00 Cr., marking a decrease of 35.00 Cr..

Notably, the Reserves (2,004.00 Cr.) exceed the Borrowings (77.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Seshasayee Paper & Boards Ltd (SESHAPAPER), here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 18.13. This value is within the healthy range. It has decreased from 44.96 (Mar 24) to 18.13, marking a decrease of 26.83.
• For Diluted EPS (Rs.), as of Mar 25, the value is 18.13. This value is within the healthy range. It has decreased from 44.96 (Mar 24) to 18.13, marking a decrease of 26.83.
• For Cash EPS (Rs.), as of Mar 25, the value is 24.63. This value is within the healthy range. It has decreased from 50.12 (Mar 24) to 24.63, marking a decrease of 25.49.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 330.30. It has increased from 317.49 (Mar 24) to 330.30, marking an increase of 12.81.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 330.30. It has increased from 317.49 (Mar 24) to 330.30, marking an increase of 12.81.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 291.43. It has decreased from 299.31 (Mar 24) to 291.43, marking a decrease of 7.88.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 29.90. This value is within the healthy range. It has decreased from 64.78 (Mar 24) to 29.90, marking a decrease of 34.88.
• For PBIT / Share (Rs.), as of Mar 25, the value is 22.38. This value is within the healthy range. It has decreased from 57.49 (Mar 24) to 22.38, marking a decrease of 35.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 20.98. This value is within the healthy range. It has decreased from 57.14 (Mar 24) to 20.98, marking a decrease of 36.16.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 17.11. This value is within the healthy range. It has decreased from 42.84 (Mar 24) to 17.11, marking a decrease of 25.73.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.13. This value is within the healthy range. It has decreased from 44.98 (Mar 24) to 18.13, marking a decrease of 26.85.
• For PBDIT Margin (%), as of Mar 25, the value is 10.26. This value is within the healthy range. It has decreased from 21.64 (Mar 24) to 10.26, marking a decrease of 11.38.
• For PBIT Margin (%), as of Mar 25, the value is 7.67. This value is below the healthy minimum of 10. It has decreased from 19.20 (Mar 24) to 7.67, marking a decrease of 11.53.
• For PBT Margin (%), as of Mar 25, the value is 7.19. This value is below the healthy minimum of 10. It has decreased from 19.08 (Mar 24) to 7.19, marking a decrease of 11.89.
• For Net Profit Margin (%), as of Mar 25, the value is 5.86. This value is within the healthy range. It has decreased from 14.31 (Mar 24) to 5.86, marking a decrease of 8.45.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.22. This value is below the healthy minimum of 8. It has decreased from 15.02 (Mar 24) to 6.22, marking a decrease of 8.80.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.49. This value is below the healthy minimum of 15. It has decreased from 14.16 (Mar 24) to 5.49, marking a decrease of 8.67.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.24. This value is below the healthy minimum of 10. It has decreased from 16.66 (Mar 24) to 6.24, marking a decrease of 10.42.
• For Return On Assets (%), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has decreased from 11.32 (Mar 24) to 4.32, marking a decrease of 7.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.04, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.71. It has decreased from 0.80 (Mar 24) to 0.71, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 3.41. This value exceeds the healthy maximum of 3. It has increased from 3.34 (Mar 24) to 3.41, marking an increase of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 2.44. This value exceeds the healthy maximum of 2. It has increased from 2.42 (Mar 24) to 2.44, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.56. This value is below the healthy minimum of 4. It has decreased from 3.90 (Mar 24) to 3.56, marking a decrease of 0.34.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 28.88. This value is within the healthy range. It has increased from 13.97 (Mar 24) to 28.88, marking an increase of 14.91.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 20.41. This value is within the healthy range. It has increased from 12.02 (Mar 24) to 20.41, marking an increase of 8.39.
• For Earning Retention Ratio (%), as of Mar 25, the value is 71.12. This value exceeds the healthy maximum of 70. It has decreased from 86.03 (Mar 24) to 71.12, marking a decrease of 14.91.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 79.59. This value exceeds the healthy maximum of 70. It has decreased from 87.98 (Mar 24) to 79.59, marking a decrease of 8.39.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 21.35. This value is within the healthy range. It has decreased from 182.22 (Mar 24) to 21.35, marking a decrease of 160.87.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.22. This value is within the healthy range. It has decreased from 121.50 (Mar 24) to 13.22, marking a decrease of 108.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 975.64. It has decreased from 1,185.43 (Mar 24) to 975.64, marking a decrease of 209.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.55, marking a decrease of 0.10.
• For EV / EBITDA (X), as of Mar 25, the value is 5.42. This value is within the healthy range. It has increased from 3.04 (Mar 24) to 5.42, marking an increase of 2.38.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.89, marking a decrease of 0.09.
• For Retention Ratios (%), as of Mar 25, the value is 71.11. This value exceeds the healthy maximum of 70. It has decreased from 86.02 (Mar 24) to 71.11, marking a decrease of 14.91.
• For Price / BV (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.78, marking a decrease of 0.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.89, marking a decrease of 0.09.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.15 (Mar 24) to 0.06, marking a decrease of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness